TG Therapeutics TGTX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's shares (diluted)?
- TG Therapeutics (TGTX) reported shares (diluted) of 160.1M in Q1 2026.
- How has TG Therapeutics's shares (diluted) changed year-over-year?
- TG Therapeutics's shares (diluted) decreased by 1.7% year-over-year, from 162.8M to 160.1M.
- What is the long-term trend for TG Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), TG Therapeutics's shares (diluted) has grown at a 5.2% compound annual growth rate (CAGR), from 528.5M to 647.7M.
- What does shares (diluted) mean?
- This represents the weighted average number of shares outstanding, adjusted for the potential issuance of shares from dilutive securities like stock options and convertible bonds. It is the denominator used for calculating diluted earnings per share. It provides a comprehensive view of the total potential equity base.